Knowledge of genomic testing among early-stage breast cancer patients.

Abstract

Genomic recurrence risk test results now inform clinical decisions about adjuvant treatment for women with early-stage breast cancer. We sought to understand patients' knowledge of these tests and correlates of their knowledge.